期刊文献+

多沙唑嗪对抗α_1受体抗体介导的糖尿病大鼠肾基质纤维化的影响

Effects of Doxazosin on Renal Matrix Fibrosis Mediated by α_1-Receptor Antibody in Diabetic Rats
原文传递
导出
摘要 目的建立具有激动样活性的抗α1肾上腺素能受体自身抗体(anti-αadrenergic receptor autoantibody,α1-AA)的糖尿病(diabetes mellitus,DM)大鼠模型,并观察该抗体对大鼠血清肌酐(serum creatinine,Scr)、尿蛋白(urine protein,Upro)、肾脏结构及Ⅳ型胶原、Smad2/3蛋白等表达及多沙唑嗪干预后的影响。方法用α1肾上腺素受体胞外第二肽段合成肽,于0、4、8、12、16周行鼠尾静脉注射法对DM大鼠进行α1-AA免疫介导(α1-AA注射量为100μg·100g-1),酶联免疫吸附法(enzyme linked immunosorbent assay,ELISA)检测α1-AA阳性率;电镜下观察肾脏的病理变化,免疫组织化学法检测大鼠肾脏组织中Ⅳ型胶原、Smad2/3蛋白分布及表达情况,并观察用受体阻断剂干预后受体阳性组大鼠的Scr、Upro、肾脏结构及Ⅳ型胶原、Smad2/3蛋白的表达情况。结果 1DM+α1-AA介导组阳性率91.7%(22/24),明显高于无介导组的27.30%及健康对照组的10.0%,差异具有统计学意义(P<0.01)。2DM+α1-AA介导组大鼠Scr和24 h Upro明显高于无介导组及健康对照组,差异具有统计学意义(P<0.01)。与无多沙唑嗪干预组相比,多沙唑嗪干预组中大鼠Scr和24 h Upro明显改善,差异具有统计学意义(P<0.01)。3电镜下观察肾脏病变发现DM+α1-AA介导组大鼠肾组织损伤最严重,DM无介导组损害不明显,DM+α1-AA介导组中干预组较无干预组病变明显减轻。4半定量分析大鼠肾组织Ⅳ型胶原、Smad2/3蛋表达结果显示,DM+α1-AA介导组MOD值显著高于无介导组(P<0.05)和健康对照组(P<0.01),DM+α1-AA介导组中干预组的上述表达明显减轻,与无干预组比较差异具有统计学意义(P<0.01)。结论通过免疫介导的方法可以建立具有激动样活性的α1-AA的大鼠模型;并证实抗α1-AA介导可致DM大鼠肾基质重构,免疫介导参与DM肾损害病理生理过程,受体拮抗剂可改善和逆转肾损害。 Objective To study renal matrix remodeling mediated by anti-α1-adrenergic receptor autoantibody(α1-AA)in rats with diabetes mellitus(DM)and investigate the effects of doxazosin intervention on renal matrix remodeling and renal functions.Methods Wistar rats were randomized into healthy blank control group,DM group,DM group withα1-AA,DM group withα1-AA and doxazosin intervention and healthy rats with doxazosin intervention.DM rat models were established by intraperitoneal injection of streptozocin and had been observed continually for 16 weeks.Rat models withα1-AA having agonist activity were established and Wistar rats in groups c and d were immunized using synthetic peptide obtained from the second extracellular peptide fragment ofα1-AA(α1-AA IV100μg·100 g-1 body weight,given as a single dose through the caudal vein at weeks 0,4,8,12,16.α1-AA was detected using enzyme-linked immunosorbent assay(ELISA).24 h urine protein(Upro)was detected by radioimmunoassay and Scr by picric acid method.The collagen Ⅳand Smad2/3 expression in renal tissue was detected by immunohistochemical method.Pathological changes of the kidney were observed under optical and electronic microscopes.Results The positive rate ofα1-AA in DM rats withα1-AA mediation was 91.7%,significantly higher than DM rats withoutα1-AA mediation(27.30%)and healthy control group(10.0%,P〈0.01).24 h Upro and Scr levels were both significantly higher in DM rats withα1-AA mediation than in DM rats without and healthy rats(P〈0.01).Under electron microscope,microstructures of renal tissue of DM rats withα1-AA mediation were seriously damaged,while mild abnormality could be found in DM rats withoutα1-AA mediation.High expression ofcollagen IV and Smad2/3 was found in the renal cortex of DM rats withα1-AA mediation,which was significantly different compared to the other 2 groups(P〈0.01 or P〈0.05).Following intervention of the receptor antagonist doxazosin,expression of collagen IV and Smad2/3significantly decreased,while renal functions and renalmatrix remodeling improved,the difference was statistically significant compared to groups without intervention(P〈0.01).Conclusion Renal matrix remodeling of DM rats is possibly associated withα1-AA-mediated immune responses.The collagenⅣ and Smad2/3 is involved in renal matrix remodeling of DM rats and plays an important role in the pathological development and progression of the disease.Receptor antagonists can reverse and improve renal functions and renal matrix remodeling.
出处 《华南国防医学杂志》 CAS 2015年第10期730-734,738,共6页 Military Medical Journal of South China
基金 湖北省自然科学基金项目(2002AB116)
关键词 多沙唑嗪 α1受体抗体 糖尿病大鼠 肾基质纤维化 Doxazosin α1-receptor antibody diabetes mellitus rats Renal matrix fibrosis
  • 相关文献

参考文献3

二级参考文献57

  • 1Bansal G, Divietro JA, Kuehn HS, Rao S, Nockal KH, Gilfillan AM, et al. RGS 13 controls GPCR-evoked responses of human mast cell. J Immmunol 2008; 181: 7882-7890.
  • 2Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, et al. Removal of cardiodepressant antibodiesin dilated cardiomyopathy by immunoadsorption. J Am Coil Cardiol 2002; 39: 646-652.
  • 3Gouwy M, Struyf S, Verbeke H, Proost P, Opdenakker G, Van Damme J. CC chemokine ligand2 synergize with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCLS. Leukoc Biol 2009; 86: 671-680.
  • 4Almeida JC, Zelmanovitz T, Vaz JS, Steemburgo T, Perassolo MS, Gross JL, et al. Sources of protein and polyunsaturated fatty acids of the diet and rnicroalbuminuria in type 2 diabetes mellitus. J Am Coll Nutr 2008; 27: 528-537.
  • 5Fioretto P, Caramori ML, Mauer M. The kidney in diabetes: dynamic pathways of injury and repair. The camillo Golgi Lecture 2007. Diabetologia 2008; 51: ! 347-1355.
  • 6Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226.
  • 7Leitao CB, Canani LH, Polson PB, Molon ME Piontti AF, Gress JL, Urinary albumin excretion rate is associated with increased ambulatory blood pressure in normoalbuminuric type 2 diabetic patients. Diabetes Care 2005; 28: 1724-1729.
  • 8Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephrophthy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164-176.
  • 9Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
  • 10Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000; 18: 945-953.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部